| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/14/2006 | EP1071468B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 06/14/2006 | EP1069890B1 Incorporation of active substances in carrier matrixes |
| 06/14/2006 | EP1032696B1 Vector for tissue-specific replication and gene expression |
| 06/14/2006 | EP1003551B1 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant |
| 06/14/2006 | EP0956360B1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses |
| 06/14/2006 | EP0783321B1 Vr-2332 viral nucleotide sequence and methods of use |
| 06/14/2006 | EP0757556B1 Borrelia burgdorferi bacterin |
| 06/14/2006 | EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 06/14/2006 | EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 06/14/2006 | EP0666868B2 Use of anti-VEGF antibodies for the treatment of cancer |
| 06/14/2006 | DE102004059357A1 New antibody (which specifically recognizes human thiamine 1) useful for blocking the binding of human Thy-1 at its ligand or for blocking the interaction of tumor cells or immune cells with endothelial cells |
| 06/14/2006 | CN1788088A Mutant vesicular stomatitis viruses and use thereof |
| 06/14/2006 | CN1788082A Cancer target direction double gene-virus, its structure method and application thereof |
| 06/14/2006 | CN1788077A Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| 06/14/2006 | CN1788019A Neutralizing antibodies against GDF-8 and uses therefor |
| 06/14/2006 | CN1787839A Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| 06/14/2006 | CN1787838A Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 06/14/2006 | CN1787837A Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/14/2006 | CN1787836A Avian combination-vaccine against e.coli and salmonella |
| 06/14/2006 | CN1787835A Human lymphocyte vaccine adjuvant |
| 06/14/2006 | CN1786298A Preparation method of anticell or tissue protein mono clone antibody stock |
| 06/14/2006 | CN1786032A Erythrogenin/immune globulin Fc fusion protein, its sypthesis method and application |
| 06/14/2006 | CN1786021A 12 amino acid analog epi-position of human B cell specificity membrane molecule CD20 and polypeptide epi-position vaccine configurated by said analog epi-position |
| 06/14/2006 | CN1785430A Nano-magnetic powder antihuman lirer cancer single anti HAb18 target medicine for magnetic heat therapy |
| 06/14/2006 | CN1785031A Ice-cream contg. immune globulin-G biological factor |
| 06/14/2006 | CN1259422C Peptides derived from attachment (G) protein of respiratory syncytial virus |
| 06/14/2006 | CN1259340C Peptide composition as immunogen for treatment of allergy |
| 06/14/2006 | CN1259339C Genetically engineering monoclonal anti-digoxin single-stranded antibody and its use |
| 06/14/2006 | CN1259106C Preparation of target gene virus medicine against cancers |
| 06/13/2006 | US7060868 Autoimmune disease model animal |
| 06/13/2006 | US7060847 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 06/13/2006 | US7060802 Monoclonal antibody hybridomas ; detecting cancer |
| 06/13/2006 | US7060800 Polypeptides for use in the treatment and diagnosis of crohn's disease |
| 06/13/2006 | US7060789 Ricin-like toxins for treatment of cancer |
| 06/13/2006 | US7060687 Live vaccines for allergy treatment |
| 06/13/2006 | US7060504 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity |
| 06/13/2006 | US7060495 Polypeptide for use in as anticarcinogenic agent |
| 06/13/2006 | US7060483 DNA encoding endo-β-galactosidase |
| 06/13/2006 | US7060466 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene |
| 06/13/2006 | US7060462 Agrobacterium tumefaciens outer membrane protein; |
| 06/13/2006 | US7060456 Regulation of human protein phosphatase IIc-like enzyme |
| 06/13/2006 | US7060453 determination of the level of glucose in non-blood sample (i.e. urine and hair) containing red blood cells; measuring the volume of blood (by measuring hemoglobin) and the amount of glucose in the sample and calculating the level of glucose in the blood based on those measurements |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |
| 06/13/2006 | US7060284 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 06/13/2006 | US7060282 Equine herpesvirus (EHV) mutants are stable and have reduced virulence, which makes them very suitable for use in a live vaccine; vaccines comprising EHV mutants, DNA sequences and vectors harbouring a mutated EHV sequence, host cells transfected with the DNA |
| 06/13/2006 | US7060281 Groups of barrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| 06/13/2006 | US7060280 Immunization against flavivirus |
| 06/13/2006 | US7060279 Compositions and methods for dendritic cell-based immunotherapy |
| 06/13/2006 | US7060278 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 06/13/2006 | US7060277 For the treatment or prophylaxis of toxic shock; peptides homologous to the amino acid sequence of a fragment of Staphylococcal aureus enterotoxin B (SEB); kits |
| 06/13/2006 | US7060276 Plasmodium falciparum AMA-1 protein and uses thereof |
| 06/13/2006 | US7060275 targets brain tumor protein targets which allow for the selective inhibition of cell function or selective marking for visualization with therapeutic or visualizing compositions which have a specific affinity for these protein targets |
| 06/13/2006 | US7060274 Receptor specific transepithelial transport of therapeutics |
| 06/13/2006 | US7060273 Methods for inhibiting HIV-1 infection |
| 06/13/2006 | US7060272 Death domain containing receptor-4 agonist antibodies and methods |
| 06/13/2006 | US7060271 Specifically bind to the extracellular domain of the human type beta PDGF receptor; diagnostic and therapeutic uses |
| 06/13/2006 | US7060270 Brain disorders; Alzheimer's disease; Down syndrome; hybridomas cell line; medical diagnosis |
| 06/13/2006 | US7060269 Anti-VEGF antibodies |
| 06/13/2006 | US7060268 Stability; freeze drying; regeneration |
| 06/13/2006 | US7060265 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 06/13/2006 | US7060262 Administering granulocyte colony stimulating factor; Crohn's disease |
| 06/13/2006 | US7060173 Using Gradiflow electrophoresis technology for macromolecule separation which utilises tangential flow across the membrane |
| 06/13/2006 | CA1341508C Transforming growth factor peptides |
| 06/08/2006 | WO2006060513A2 Toll like receptor 3 antagonists, methods and uses |
| 06/08/2006 | WO2006060484A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 06/08/2006 | WO2006060419A2 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 06/08/2006 | WO2006060332A2 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 06/08/2006 | WO2006060257A2 Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof |
| 06/08/2006 | WO2006060051A2 Enzyme chimeras and methods of their use for the treatment of infection by bacillus anthracis |
| 06/08/2006 | WO2006060021A2 Bifunctional fusion proteins containing the flt3 ligand |
| 06/08/2006 | WO2006060020A1 Sm5-1 antibodies and applications thereof |
| 06/08/2006 | WO2006059914A1 Modulation of ovulation |
| 06/08/2006 | WO2006059913A1 Modulation of ovulation |
| 06/08/2006 | WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase |
| 06/08/2006 | WO2006059637A1 Agent for diagnosing, preventing and treating adhesion with the use of ccr8 inhibitor |
| 06/08/2006 | WO2006059529A1 Hla-a24-restricted tumor antigen peptide |
| 06/08/2006 | WO2006059176A1 Naturally occuring igm antibodies that bind lymphocytes |
| 06/08/2006 | WO2006059142A1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 06/08/2006 | WO2006059131A1 T-cell modulation |
| 06/08/2006 | WO2006059009A1 Novel pharmaceutical composition useful for vaccines |
| 06/08/2006 | WO2006014683A3 Immunoglobulins comprising predominantly a gal2glcnac2man3glcnac2 glycoform |
| 06/08/2006 | WO2006012508A3 Method of treating sjögren's syndrome |
| 06/08/2006 | WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/08/2006 | WO2005123908A3 Novel cancer cell lines and uses thereof |
| 06/08/2006 | WO2005123762B1 Codon-optimized HPV16 li for salmonella vaccine strains against human papillomavirus type 16 |
| 06/08/2006 | WO2005120563A3 Induction of an immune response against streptococcus pneumoniae polysaccharides |
| 06/08/2006 | WO2005117968A3 Compositions and methods comprising an egfl7 antagonist for modulating vascular development |
| 06/08/2006 | WO2005117957A3 Compositions and methods involving o-acetylated group b streptococcus capsular polysaccharides |
| 06/08/2006 | WO2005113600A3 Methods for the control, treatment and management of obesity |
| 06/08/2006 | WO2005112985A3 Means and method for diagnosis prophylaxis and therapy of connective tissue diseases |
| 06/08/2006 | WO2005111079A3 Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41 |
| 06/08/2006 | WO2005092926A3 Reducing the risk of human and anti-human antibodies through v gene manipulation |
| 06/08/2006 | WO2005092372A3 Modified bacillus anthracis vaccine compositions and methods of use thereof |
| 06/08/2006 | WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/08/2006 | WO2005090393A3 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 06/08/2006 | WO2005089043A3 Prostate stem cell |
| 06/08/2006 | WO2005084194A3 Methods of evaluating efficacy of an immune response by assessing alpha-1 integrin expression |
| 06/08/2006 | WO2005023862A9 Homogeneous preparations of IL-28 and IL-29 |
| 06/08/2006 | WO2005023191A3 Rage-related methods and compositions for treating glomerular injury |
| 06/08/2006 | WO2004073653A3 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |